Cord Blood Education for Parents, Health Professionals and Students - Save the Cord Foundation
  • Home
  • Step-by-Step
  • LEARN
    • Cord Blood Facts
    • Types of stem cells
    • Diseases Treated >
      • Regenerative Medicine: Cord Blood is Critical
      • Participate in a Cord Blood Clinical Trial
    • Cord Blood FAQs
    • Cord Blood News >
      • RESEARCH
      • PROJECTS and EVENTS
      • RESOURCES
    • Video Gallery
    • Find a Cord Blood Bank
  • Get Involved
    • ABOUT US >
      • Scientific Advisory Board
      • Inspiring Partners
      • FACT Allied Learning Center
    • Register for Newsletter
    • Our Work in Action >
      • World Cord Blood Day
      • Arizona Public Cord Blood Program
      • Share the Science
      • NEXT GENERATION: Cord Blood
      • Cord Blood Conferences & Workshops
      • World Cancer Day
    • Cord Blood Education Champions
    • Internship Program at University of Arizona
    • Start a Cord Blood Donation Program
    • Contact Us
  • DONATE
  • Spanish Version
    • Step-by-Step Spanish
    • APRENDER >
      • Datos de la sangre del cordón
      • Tipos de celdas
    • ENCUENTRE UN BANCO
    • PARTICIPE >
      • COMENZAR UN PROGRAMA DE DONACION
    • DONAR
    • VIDEOS EN ESPAÑOL
    • NOTICIAS DE LA SANGRE DEL CORDON >
      • Curar la diabetes con sangre del cordón?
      • Ensayos Clinicos
      • Dia Mundial de la Sangre del Cordón Umbilical
      • Controversia respecto a las células madre
      • Medicina regenerativa
      • Sangre del Cordón Umbilical en Arizona 2018
  • Search
  • Home
  • Step-by-Step
  • LEARN
    • Cord Blood Facts
    • Types of stem cells
    • Diseases Treated >
      • Regenerative Medicine: Cord Blood is Critical
      • Participate in a Cord Blood Clinical Trial
    • Cord Blood FAQs
    • Cord Blood News >
      • RESEARCH
      • PROJECTS and EVENTS
      • RESOURCES
    • Video Gallery
    • Find a Cord Blood Bank
  • Get Involved
    • ABOUT US >
      • Scientific Advisory Board
      • Inspiring Partners
      • FACT Allied Learning Center
    • Register for Newsletter
    • Our Work in Action >
      • World Cord Blood Day
      • Arizona Public Cord Blood Program
      • Share the Science
      • NEXT GENERATION: Cord Blood
      • Cord Blood Conferences & Workshops
      • World Cancer Day
    • Cord Blood Education Champions
    • Internship Program at University of Arizona
    • Start a Cord Blood Donation Program
    • Contact Us
  • DONATE
  • Spanish Version
    • Step-by-Step Spanish
    • APRENDER >
      • Datos de la sangre del cordón
      • Tipos de celdas
    • ENCUENTRE UN BANCO
    • PARTICIPE >
      • COMENZAR UN PROGRAMA DE DONACION
    • DONAR
    • VIDEOS EN ESPAÑOL
    • NOTICIAS DE LA SANGRE DEL CORDON >
      • Curar la diabetes con sangre del cordón?
      • Ensayos Clinicos
      • Dia Mundial de la Sangre del Cordón Umbilical
      • Controversia respecto a las células madre
      • Medicina regenerativa
      • Sangre del Cordón Umbilical en Arizona 2018
  • Search

Share the Science: Regenerative Stem Cell Therapies for the Wounded Warrior - Dr. Lloyd Rose

10/8/2020

 
Picture
Save the Cord Foundation and WellSky are proud to welcome Dr. Lloyd Rose of US Army Medical Material Development Activity, as our featured speaker for our next edition of Share the Science on October 22nd, 2020. Join us to hear Dr. Rose present his research regarding regenerative stem cell therapies and how the US Department of Defense is harnessing this research to help injured soldiers. Recording now available . Click here to view.
​
Share the Science is a free webinar series focused on the cord blood industry and the latest research in this field.  As always, we invite both health professionals and the general public to join us for this unique online educational series. Learn more about this exciting educational series here.

Department of Defense Harnessing Stem Cell Therapies

The last two decades have seen great improvement in our ability to keep traumatically injured soldiers alive from wounds that previously would have proven fatal.  However, the result has been an increase in severe functional deficits due to loss of tissue and limbs. 
 
Harnessing stem cell therapies to regenerate lost or damaged tissue holds out hope for restoring our Wounded Warriors to full functionality and improving their quality of life.
  • Learn what the Department of Defense (DoD) is doing to support cell therapies for traumatic injury
  • Examine the manufacturing and regulatory roadblocks to cell therapies and tissue engineered medical products, and what can be done to overcome them
  • See the work being done to manufacture red blood cells at scale and at point of need

Register now to discover some of the extraordinary work the DoD is doing in cell therapy and regenerative medicine to address traumatic injuries, especially those suffered by Military personnel.

SHARE THE SCIENCE
with
Lloyd Rose, PhD


Regenerative Medicine Portfolio Manager, Clinical and Rehabilitative Medicine Research Program
US Army Medical Material Development Activity

"Stem Cell Therapies for the Wounded Warrior"

Free webinar.  Open to the public.
​
Thursday, October 22nd - 2pm Eastern Time/ 11am Pacific Time

CLICK HERE TO WATCH THE RECORDING
Watch the Recording: Share the Science with Dr. Lloyd Rose

About the speaker

​Dr. Rose is responsible for planning, budgeting, and execution of Army, Defense Health Program and Congressional Special Interest funds directed toward dynamic and innovative regenerative medicine research. After earning a Ph.D. in Microbiology and Immunology from the University of Texas Health Science Center at San Antonio, he began a postdoctoral fellowship at the U.S Army Institute of Surgical Research working on burns, scarring, and skin regeneration. In 2015, he moved to the U.S. Army Medical Research and Material Command, Fort Detrick, Maryland to manage research projects in Regenerative Medicine.
Picture

We wish to thank Dr. Lloyd Rose for volunteering his time to speak on
Share the Science and sharing his valuable insight
on regenerative stem cell therapies for injured soldiers.
​
We also wish to also thank our generous sponsor and partner for this event,
WellSky Health, who continue to support cord blood
education through our “Share the Science” series.
Picture
Picture

Share the Science: Chimeric Antigen Receptor T (CAR-T) Cell Therapy for Lymphoma

9/10/2020

 
Picture
​Save the Cord Foundation and WellSky are proud to welcome Sairah Ahmed, M.D. from the University of Texas - MD Anderson Cancer Center, as our featured speaker for our next edition of Share the Science on September 24th, 2020. Join us to hear Dr. Ahmed present her research regarding CAR-T Cell therapy and the multiple constructs of CAR-T therapy, and when they are effective for the treatment of certain types of lymphoma. RECORDING NOW AVAILABLE:  VIEW IT HERE.
​
Share the Science is a free webinar series focused on the cord blood industry and the latest research in this field.  As always, we invite both health professionals and the general public to join us for this unique online educational series. Learn more about this exciting educational series here.

Latest Research: CAR-T Cell Therapy for Lymphoma

We are thrilled to welcome Dr. Sairah Ahmed as our next featured speaker on Share the Science. We have had many requests from the Save the Cord community to highlight the latest research in CAR-T cell therapy and as it relates to cord blood. Indeed, this is a new and emerging area of scientific research with great promise. Given that we welcome not only healthcare professionals to our webinars but also the general public, we feel it is important to give you a brief overview of the basics regarding CAR-T cell therapy.
What is CAR-T Cell Therapy?

A type of treatment in which a patient's T cells (a type of immune system cell) are changed in the laboratory so they will attack cancer cells. T cells are taken from a patient’s blood. Then the gene for a special receptor that binds to a certain protein on the patient’s cancer cells is added to the T cells in the laboratory. The special receptor is called a chimeric antigen receptor (CAR). Large numbers of the CAR T cells are grown in the laboratory and given to the patient by infusion. CAR T-cell therapy is used to treat certain blood cancers, and it is being studied in the treatment of other types of cancer. Also called chimeric antigen receptor T-cell therapy.

Source: National Cancer Institute
Picture
In this special webinar focused on CAR-T Cell Therapy, Dr. Ahmed will discuss how cord blood sources play a critical role in treating select lymphomas including the potential of using CAR-T cell therapy.  This method of treatment shows particular promise in treating lymphomas that are not responding to other methods. During Dr. Ahmed's presentation she will highlight which patients are the best candidates for treatment with CAR-T therapy and how is CAR-T therapy different from autologous transplant for lymphoma.  She will also discuss which types of lymphoma can be treated with CAR-T therapy.  The toxicity specific to CAR-T therapy, as well as novel lymphoma cellular therapy treatment from cord blood sources will also be discussed. 
SHARE THE SCIENCE
with
Sairah Ahmed, M.D.


Associate Professor, Department of Lymphoma/Myeloma, Division of Cancer Medicine
​The University of Texas MD Anderson Cancer Center, Houston, TX

"Chimeric Antigen Receptor T (CAR-T) Cell Therapy for Lymphoma"

Free webinar.  Open to the public.
​
Thursday, September 24th - 2pm Eastern Time/ 11am Pacific Time

RECORDING NOW AVAILABLE
WATCH THE RECORDING: Share the Science: Dr. Sairah Ahmed, MD - CAR-T Cell Therapy

About the speaker

Picture
​
​Dr. Sairah Ahmed received her medical degree from Khyber Medical College in Pakistan. Prior to joining MD Anderson, Dr. Ahmed was Chief Fellow of Hematology/Oncology at Northwestern University. She is passionate about stem cell transplantation and cellular therapy.

We wish to thank Dr. Sairah Ahmed for volunteering her time to speak on
Share the Science and sharing her valuable insight
on CAR-T Cell Therapies using cord blood.
​
We also wish to also thank our generous sponsor and partner for this event,
WellSky Health, who continue to support cord blood
education through our “Share the Science” series.
Picture
Picture

Share the Science: Immune Reconstitution after Cord Blood Transplantation - Jaap Jan Boelens, MD, PhD

8/5/2020

 
Picture
Save the Cord Foundation and WellSky are proud to welcome Jaap Jan Boelens, MD, PhD from Memorial Sloan Kettering Cancer Center, as our featured speaker for our next edition of Share the Science on August 20th, 2020. Join us to hear Dr. Boelens present his research on cord blood transplants and the numerous factors influencing hematopoietic cell transplantation (HCT) outcomes. Recording now available, see below.
​
Share the Science is a free webinar series focused on the cord blood industry and the latest research in this field.  As always, we invite both health professionals and the general public to join us for this unique online educational series. Learn more about this exciting educational series here.
Understanding the nuances of cord blood transplantation, pre- and post-transplant, are key to treating any patient undergoing this procedure.  Often the patient's survival and quality of life post-transplant is driven by their body's ability to rebuild the immune system. Join us on August 20th to learn how transplant doctors can exploit cord blood's unique qualities during this process of recovery and period of reconstitution. Dr. Jaap Boelens will present his latest research in this area and explain how reconstituting immune cells from cord blood differs from other stem cell sources. 

Many factors influence HCT outcomes, such as the selected graft source, type of infused cell subsets, cell doses, and the protocols used for conditioning, immune suppression, and treatment of adverse events. Recent pharmacokinetic studies show that compounds used in the conditioning regimen (e.g. busulphan, fludarabine, anti-thymocyte globulin) should use patient-specific dosing to achieve optimal exposure in every individual patient.

Attendees of this Share the Science webinar will learn:
  • What unique anti-viral and tumor features are present in cord blood T cells
  • How CD4+ reconstitution of only 50/uL is an excellent predictor for outcomes after transplantation
  • Why the dosing of agents given in the conditioning regimen can have significant impact on reconstitution of immune cells
  • Due to a multitude of variables, harmonization between HCT centers is still difficult to achieve. Dr. Boelens will share his investigations to improve immune recovery after HCT to limit both relapse and non-relapse mortality (death due to viral reactivations and graft-versus-host disease).
SHARE THE SCIENCE
with
Jaap Jan Boelens, MD, PhD


Chief, Stem Cell Transplantation and Cellular Therapies
Memorial Sloan Kettering Cancer Center

"Immune Reconstitution after Cord Blood Transplantation"

Free webinar.  Open to the public.
​
Thursday, August 20th - 12 noon Eastern Time/ 9am Pacific Time

RECORDING NOW AVAILABLE
Click here to watch Share the Science with Jaap Jan Boelens, MD, PhD

About the speaker

Picture
​Jaap Jan Boelens, MD, PhD is a pediatric hematologic oncologist and Chief of the Pediatric Stem Cell Transplantation and Cellular Therapies Service at Memorial Sloan Kettering Cancer Center. Dr. Boelens has particular expertise caring for people with rare diseases, such as lysosomal storage disorders like Hurler’s disease and leukodystrophies like metachromatic leukodystrophy, adrenoleukodystrophy, and Krabbe disease.

We wish to thank Dr. Jaap Jan Boelens for volunteering his time to speak on
Share the Science and sharing his valuable insight
on immune reconstitution after cord blood transplantation.

​
We also wish to also thank our generous sponsor and partner for this event,
WellSky Health, who continue to support cord blood
education through our “Share the Science” series.
Picture
Picture
<<Previous

    Author

    Write something about yourself. No need to be fancy, just an overview.

    Archives

    October 2020
    September 2020
    August 2020
    June 2020
    May 2020
    March 2020
    October 2019
    August 2019
    May 2019
    April 2019
    March 2019
    February 2019
    November 2018
    August 2018
    January 2018
    October 2017
    September 2017
    June 2017
    May 2017
    April 2017
    March 2017
    February 2017
    January 2017
    December 2016
    November 2016
    October 2016
    September 2016
    August 2016
    June 2016
    March 2016
    January 2016
    December 2015
    November 2015

    Categories

    All
    Projects And Events
    Research
    Share The Science

    RSS Feed

About Save the Cord Foundation

Picture
Save the Cord Foundation, a 501c3 non-profit organization, was established to promote awareness of the life-saving benefits of cord blood based on u​nbiased and factual information. The Foundation educates parents, health professionals and the general public about the need to preserve this valuable medical resource while providing information on both public cord blood donation programs and private family cord blood banks worldwide. Learn more about our global community.

Show your Support

Our mission depends on supporters like you. Please support our cause by making a donation or promoting our website and message where you can. We appreciate all the support!
Picture

Follow us on social media

Join the conversation

Tweets by @SaveTheCord
Copyright 2018 - All rights reserved. - Privacy Policy - Terms and Conditions
Photos used under Creative Commons from gromin, Mohammed A. Fadil